Belpointe OZ announced a development agreement for a luxury multifamily project in affluent Darien, Connecticut, without initial cash investment.
Quiver AI Summary
Belpointe PREP, LLC, operating as Belpointe OZ, has announced an agreement for a development site at 100 Tokeneke Road in Darien, Connecticut, a wealthy residential market. The property will be contributed by the seller in exchange for equity in the project entity, allowing Belpointe to engage in a luxury multifamily development without initial cash outlay. The company plans to provide future capital for the project's development or financing through an affiliated investment vehicle. This agreement could also allow Belpointe to buy out the seller at a predetermined valuation, enhancing long-term alignment of interests. The CEO emphasized the significant growth potential in Darien due to its supply constraints and proximity to New York City. Belpointe OZ, listed on NYSE American, has an extensive development pipeline across multiple cities.
Potential Positives
- Belpointe OZ acquired a prime development site in Darien, Connecticut, a highly affluent market with limited multifamily inventory, which positions the company for potential long-term value creation.
- The transaction was structured without upfront cash consideration, allowing Belpointe OZ to preserve capital while still engaging in the development of a luxury multifamily project.
- The agreement includes a mechanism for Belpointe OZ to potentially buy out the Property's seller using Class A units, aligning long-term incentives and maintaining financial flexibility.
Potential Negatives
- The company engaged in a transaction without any upfront cash consideration, which may raise concerns about liquidity and capital management.
- The reliance on future capital contributions for project financing indicates potential financial instability or uncertainty regarding immediate funding sources.
- The warning about high investment risks associated with the Class A units suggests that potential investors should be cautious, which could deter new investment and affect market perception negatively.
FAQ
What is Belpointe OZ's latest development project?
Belpointe OZ has announced a new luxury multifamily project at 100 Tokeneke Road in Darien, Connecticut.
How was the property acquired by Belpointe OZ?
The property was contributed by the seller in exchange for equity in the project, with no upfront cash from Belpointe OZ.
Why is Darien, Connecticut, significant for this project?
Darien is a wealthy, supply-constrained market with strong demand due to its proximity to New York City and excellent schools.
What are Class A units in Belpointe OZ?
Class A units represent limited liability interests in Belpointe OZ, which have been registered for public sale with the SEC.
What risks are associated with investing in Belpointe OZ?
Investing in Belpointe OZ's Class A units involves high risks, including the potential for complete loss of investment.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$OZ Hedge Fund Activity
We have seen 12 institutional investors add shares of $OZ stock to their portfolio, and 15 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OSAIC HOLDINGS, INC. added 56,347 shares (+inf%) to their portfolio in Q3 2025, for an estimated $3,606,208
- HILLTOP HOLDINGS INC. added 30,700 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,964,800
- UBS GROUP AG removed 12,793 shares (-72.1%) from their portfolio in Q3 2025, for an estimated $818,752
- CITADEL ADVISORS LLC added 5,808 shares (+inf%) to their portfolio in Q3 2025, for an estimated $371,712
- XTX TOPCO LTD removed 4,574 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $292,736
- BISON WEALTH, LLC removed 4,534 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $290,176
- BROOKWOOD INVESTMENT GROUP LLC added 4,115 shares (+16.0%) to their portfolio in Q3 2025, for an estimated $263,360
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
Greenwich, Connecticut, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Belpointe PREP, LLC (“Belpointe OZ,” “we,” “us,” “our” or the “Company”) (NYSE American: OZ), a publicly traded qualified opportunity fund, announced today that the Company entered into an agreement relating to a development site located at 100 Tokeneke Road in Darien, Connecticut (the “Property”), one of the most affluent and supply-constrained residential markets in the region.
The Property is being contributed by the seller to an indirect subsidiary of Belpointe OZ in exchange for equity in the project entity. The transaction was completed without any upfront cash consideration from Belpointe OZ, though the Company intends to provide future capital in connection with the project’s development or financing, either directly or indirectly through an affiliated investment vehicle organized for that purpose. The structure establishes an initial framework for our participation in the long-term development and ownership of a ground-up luxury multifamily project in one of the most exclusive residential communities in the country.
Darien consistently ranks among the wealthiest towns in America, with limited multifamily inventory and strong long-term demand driven by proximity to New York City, top-tier schools, and a highly affluent resident base.
In addition, the agreement provides a mechanism by which Belpointe OZ may buy out the Property’s seller at a pre-agreed valuation, payable in our Class A units, further aligning long-term incentives while preserving balance-sheet flexibility.
“This transaction provides Belpointe OZ with exposure to a rare ground-up residential development opportunity in one of the highest-barrier-to-entry markets in the country,” said Brandon Lacoff, Chairman and CEO of Belpointe OZ. “We believe Darien’s demographic profile, supply constraints, and proximity to New York City create a compelling backdrop for long-term value creation.”
About Belpointe OZ
Belpointe OZ is a publicly traded qualified opportunity fund, listed on NYSE American under the symbol “OZ.” To date, Belpointe OZ has over 2,000 units in its development pipeline throughout four cities, representing an approximate total project cost of over $1.0 billion.
Belpointe OZ has filed a registration statements (including a combined prospectus) with the U.S. Securities and Exchange Commission (“SEC”) for the offer and sale of up to an aggregate of $750,000,000 of Class A units representing limited liability interests in Belpointe OZ (the “Class A units”). Before you invest, you should read Belpointe OZ’s most recent prospectus and the other documents that it has filed with the SEC for more complete information about Belpointe OZ and the offering. Investing in Belpointe OZ’s Class A units involves a high degree of risk, including a complete loss of investment. Prior to making an investment decision, you should carefully consider Belpointe OZ’s investment objectives and strategy, risk factors, fees and expenses and any tax consequences that may results from an investment in Belpointe OZ’s Class A units. To view Belpointe OZ’s most recent prospectus containing this and other important information visit sec.gov or investors.belpointeoz.com . Alternatively, you may request Belpointe OZ send you the prospectus by calling (203) 883-1944 or emailing [email protected] . Read the prospectus in its entirety before making an investment decision.
Cautionary Note Regarding Forward-Looking Statements
This press release (this “Press Release”) contains express or implied “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to qualify for the “safe harbor” from liability established by those sections. Forward-looking statements are based on our current beliefs and assumptions, and on information currently available to us, and only speak as of the date of this Press Release. All statements other than statements of historical fact, such as statements containing estimates, projections and other forward-looking information, are forward-looking statements. Forward-looking statements are typically identified by words and phrases such as “anticipate,” “estimate,” “believe,” “continue,” “could,” “intend,” “may,” “plan,” “potential,” “predict,” “seek,” “should,” “will,” “would,” “expect,” “objective,” “projection,” “forecast,” “goal,” “guidance,” “outlook,” “effort,” “target” or the negative of such words and other comparable terminology. However, the absence of these words does not mean that a statement is not forward-looking. Any forward-looking statements expressing an expectation or belief as to future events is expressed in good faith and believed to be reasonable at the time such forward-looking statement is made. However, these statements are not guarantees of future events and involve risks, uncertainties and other factors beyond our control, including factors described in our filings with the SEC, such as those detailed under the heading “Risk Factors” in our annual report on Form 10-K and quarterly reports on Form 10-Q. We cannot provide you with assurance that any of the assumptions upon which our forward-looking statements are based will prove to be correct. Should one or more risks materialize, or should our underlying assumptions prove incorrect, actual results may vary materially from those expressed or implied in any forward-looking statements, and you are therefore cautioned against placing undue reliance on any forward-looking statements. Except as otherwise required by applicable law, including federal securities laws, we do not intend to update or revise any forward-looking statements as a result of new information, future events, actual results, revised expectations or otherwise We further expressly disclaim any written or oral statements made by a third party regarding the subject matter of this Press Release.
Investor Relations and Media Contact:
Cody H. Laidlaw
Belpointe PREP, LLC
255 Glenville Road
Greenwich, Connecticut 06831
[email protected]
203-883-1944